Cyanotech Corporation

CYAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $1.4M $1.2M $2.2M $4.3M $4.4M $5.1M $2.1M
Accounts Receivable $2.1M $3.0M $3.3M $2.4M $3.8M $2.4M $2.6M
Inventory $8.0M $7.9M $5.7M $5.3M $3.7M $3.5M $3.6M
Total Current Assets $12.2M $12.7M $11.8M $12.6M $12.2M $11.4M $8.5M
Property, Plant & Equipment $16.7M $17.8M $14.8M $14.8M $11.8M $5.8M $4.6M
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $29.2M $31.1M $30.9M $30.0M $28.6M $19.0M $13.9M
Liabilities
Accounts Payable $3.7M $4.0M $2.9M $3.1M $1.9M $1.7M $1.1M
Total Current Liabilities $6.0M $6.1M $4.3M $4.2M $2.9M $3.4M $2.2M
Long-Term Debt $6.5M $7.4M $5.1M $5.3M $5.5M $400.0K $553.0K
Total Liabilities $12.6M $13.3M $9.4M $9.4M $8.4M $3.8M $2.7M
Stockholders' Equity
Retained Earnings $-15.1M $-13.9M $-9.5M $-9.5M $-9.0M $-13.2M $-16.8M
Total Stockholders' Equity $16.6M $17.8M $21.5M $20.6M $20.2M $15.2M $11.1M
← Newer Page 2 of 2 Older →